HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aveeno receives AAD seal

This article was originally published in The Rose Sheet

Executive Summary

Two Aveeno-brandContinuous Protection Sunblock Lotions are the first products ever to be awarded the American Academy of Dermatology's AAD Seal Of Recognition, Johnson & Johnson announces June 6. The products - Aveeno Continuous Protection Sunblock Lotion SPF 55 and Aveeno Baby Continuous Protection Sunblock Lotion SPF 55 - contain Active Photobarrier Complex, which employs avobenzone and oxybenzone "to deliver optimal, broad and photostable UVA/UVB protection over time," J&J says. The AAD Seal Of Recognition program, conceived to educate the public about exposure to the sun and associated health risks, recognizes sunscreens of SPF 15 or higher that have met FDA standards of documentation, according to AAD's Web site...

Two Aveeno -brand Continuous Protection Sunblock Lotions are the first products ever to be awarded the American Academy of Dermatology's AAD Seal Of Recognition , Johnson & Johnson announces June 6. The products - Aveeno Continuous Protection Sunblock Lotion SPF 55 and Aveeno Baby Continuous Protection Sunblock Lotion SPF 55 - contain Active Photobarrier Complex , which employs avobenzone and oxybenzone "to deliver optimal, broad and photostable UVA/UVB protection over time," J&J says. The AAD Seal Of Recognition program, conceived to educate the public about exposure to the sun and associated health risks, recognizes sunscreens of SPF 15 or higher that have met FDA standards of documentation, according to AAD's Web site....

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014779

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel